Behind the new quest for the moa’s return stands a powerful collaboration, linking ancient wisdom, cutting-edge science, and global ambition.
Colossal Biosciences, a Texas-based biotech firm with a portfolio that includes efforts to revive the woolly mammoth, dodo, thylacine, and dire wolf, has set its sights on the moa.
Joined by acclaimed director and moa enthusiast Peter Jackson, whose collection of moa bones ranks among the world’s largest, the company has committed more than $15 million to the cause.
At the heart of this venture is the Ngāi Tahu Research Centre, based at the University of Canterbury and representing New Zealand’s principal Māori tribe of the south.
The initiative is uniquely Māori-led, with tribal experts setting the direction, pace, and cultural protocols for every stage of research.
Their deep relationship with the land and its creatures ensures that the revival project honors not only scientific progress but also spiritual, cultural, and ecological dimensions.
Dozens of scientists, including Paul Scofield, New Zealand’s leading moa researcher, and archaeologist Kyle Davis, have joined forces to gather well-preserved bones and ancient DNA.
Cave expeditions and fossil digs are ongoing, with over sixty individual specimens sampled to reconstruct the genomes of all nine moa species.
Colossal’s previous achievements, such as the functional de-extinction of dire wolves, provide a technological springboard for this avian challenge.
Museums, Indigenous archives, and private collections offer a trove of bones, eggshell fragments, and even feathers, holding genetic secrets from the ancient world.
The endeavor has become more than a scientific mission; it is a journey into memory, identity, and hope for ecological restoration.